Published February 28, 2024 | Version v1
Journal article Open

Malaria's molecular dance: Mechanism, therapies, and emerging insights

Description

Malaria, caused by Plasmodium parasites and transmitted through Anopheles mosquitoes, remains a formidable global health challenge. This abstract provides an overview of the intricate molecular mechanisms underlying malaria pathogenesis, explores current therapeutic approaches, and highlights emerging insights that may shape future strategies for malaria control. The intricate dance between Plasmodium parasites and their human hosts begins with the mosquito's bite, leading to the invasion of erythrocytes by Plasmodium species. We delve into the molecular mechanisms governing parasite entry and subsequent replication within host cells, shedding light on key factors such as erythrocyte surface receptors and parasite-encoded proteins critical to invasion and survival. While malaria treatment has relied heavily on antimalarial drugs, the emergence of drug resistance necessitates ongoing exploration of novel therapeutic strategies. This abstract reviews current antimalarial drug classes, their mechanisms of action, and the challenges posed by drug resistance. We also highlight promising drug candidates and innovative approaches in the pipeline, including the use of advanced molecular techniques and immunotherapies. Emerging insights from genomics, proteomics, and transcriptomics have deepened our understanding of Plasmodium biology and host-parasite interactions. We discuss the potential of these omics approaches in identifying new drug targets, understanding drug resistance mechanisms, and developing vaccines. Additionally, we examine the role of human genetics in influencing susceptibility to malaria and response to treatment. Vector control remains a critical component of malaria prevention. We touch upon emerging strategies, such as genetically modified mosquitoes and novel insecticides, in the context of integrated vector management programs. Finally, we emphasize the importance of a multifaceted approach to malaria control, combining advances in molecular biology, drug development, vector control, and public health interventions.

Files

PHAR_article_117145.pdf

Files (1.1 MB)

Name Size Download all
md5:09cdd42f47c7d7c87ae08207a5256324
932.4 kB Preview Download
md5:0ccd74da9215e814efdd8c78c21ecdb2
134.2 kB Preview Download

Additional details

References

  • Anggriyani R (2023) Penyakit malaria akibat infeksi Plasmodium sp. terhadap darah manusia. Jurnal Penelitian Biologi, Botani, Zoologi, dan Mikrobiologi 8(1): e32. https://doi.org/10.33019/ekotonia.v8i1.4128
  • Arisco NJ, Peterka C, Castro MC (2021) Cross-border malaria in Northern Brazil. Malaria Journal 20: e135. https://doi.org/10.1186/s12936-021-03668-4
  • Arrow KJ, Panosian C, Gelband H (2004) Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance. National Academies Press.
  • Arya A, Kojom Foko LP, Chaudhry S, Sharma A, Singh V (2021) Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions – India and sub-Saharan Africa. International Journal for Parasitology. Drugs and Drug Resistance 15: 43–56. https://doi.org/10.1016/j.ijpddr.2021.01.003
  • Asmara I (2018) Infeksi malaria Plasmodium knowlesi pada manusia. Jurnal Penyakit Dalam Indonesia 5(4): e201.
  • Azmi WA, Rizki AFM, Djuardi Y, Artika IM, Siregar JE (2023) Molecular insights into artemisinin resistance in Plasmodium falciparum: An updated review. Infection, Genetics and Evolution 112: e105460. https://doi.org/10.1016/j.meegid.2023.105460
  • Boni MF, Smith DL, Laxminarayan R (2008) Benefits of using multiple first-line therapies against malaria. Proceedings of the National Academy of Sciences of the United States of America 105(37): 14216–14221. https://doi.org/10.1073/pnas.0804628105
  • De Koning-Ward TF, Gilson PR, Crabb BS (2015) Advances in molecular genetic systems in malaria. Nature Reviews Microbiology 13(6): 374–387. https://doi.org/10.1038/nrmicro3470
  • Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NPJ, Lindegardh N, Socheat D, White NJ (2009) Artemisinin resistance in Plasmodium falciparum malaria. The New England Journal of Medicine 361: 455–467. https://doi.org/10.1056/NEJMoa0808859
  • Ecker A, Lehane AM, Clain J, Fidock DA (2012) PfCRT and its role in antimalarial drug resistance. Trends in Parasitology 28(11): 504–514. https://doi.org/10.1016/j.pt.2012.08.005
  • Fambirai T, Chimbari MJ, Ndarukwa P (2022) Global cross-border malaria control collaborative initiatives: A scoping review. International Journal of Environmental Research and Public Health 19(19): e12216. https://doi.org/10.3390/ijerph191912216
  • Feachem RG, Sabot O (2008) A new global malaria eradication strategy. Lancet 371: e1634. https://doi.org/10.1016/S0140-6736(08)60424-9
  • Fikadu M, Ashenafi E (2023) Malaria: An overview. Infection and Drug Resistance 16(1): 3339–3341. https://doi.org/10.2147/IDR.S3339
  • Fitri LE, Widaningrum T, Endharti AT, Prabowo MH, Winaris N, Nugraha RYB (2022) Malaria diagnostic update: From conventional to advanced method. Journal of Clinical Laboratory Analysis 36(4): e24234. https://doi.org/10.1002/jcla.24234
  • Fitriany J, Sabic A (2018) Malaria. Jurnal Averrous 4(2): 6–7. https://doi.org/10.29103/averrous.v4i2.1039
  • Giribaldi G, Alessandro SD, Prato M, Basilico N (2015) Etiopathogenesis and pathophysiology of malaria. In: Giribaldi G, Alessandro SD, Prato M, Basilico N (Eds) Malaria: Biology in the Era of Eradication. Springer International Publishing, 4 pp. https://doi.org/10.1007/978-3-319-09432-8_1
  • Gosling RD, Whittaker M, Gueye CS, Fullman N, Baquilod M, Kusriastuti R, Feachem RG (2012) Malaria elimination gaining ground in the Asia Pacific. Malaria Journal 11: e346. https://doi.org/10.1186/1475-2875-11-346
  • Hakim L, Hadi UK, Sugiarto S (2018) Kajian pengendalian malaria di Provinsi Sumatera Utara dalam upaya mencapai eliminasi malaria. Jurnal Vektor Penyakit 12(1): 47–56. https://doi.org/10.22435/vektorp.v12i1.286
  • Harijanto (2010) Treatment malaria menggunakan artemisinin di Indonesia. Acta Medica Indonesiana 42(1): 1–5. https://www.actamedindones.org/index.php/ijim/article/view/379
  • Kinansi RR, Pratamawati DA, Mayasari R (2021) Pengobatan malaria di perkotaan dan pedesaan di Indonesia (Analisis lanjut Riskesdas 2013). Jurnal Litbang Pengendalian Penyakit Bersumber Binatang Banjarnegara, Balaba, 179–190. https://doi.org/10.22435/blb.v17i2.4443
  • Krampa FD, Anweh Y, Awandare GA, Kanyong P (2017) Recent progress in the development of diagnostic tests for malaria. Diagnostics 7(3): e54. https://doi.org/10.3390/diagnostics7030054
  • Krisher LK, Krisher J, Ambuludi M, Arichabala A, Beltrán-Ayala E, Navarrete P, Ordoñez T, Polhemus ME, Quintana F, Rochford R, Silva M, Bazo J, Stewart-Ibarra AM (2016) Successful malaria elimination in the Ecuador-Peru border region: Epidemiology and lessons learned. Malaria Journal 15: e573. https://doi.org/10.1186/s12936-016-1630-x
  • Lee WC, Cheong FW, Amir A, Lai MY, Tan JH, Phang WK, Shahari S, Lau Y-L (2022) Plasmodium knowlesi: The game-changer for malaria eradication. Malaria Journal 21(140): 18–19. https://doi.org/10.1186/s12936-022-04132-1
  • Lewinsca MY, Raharjo M, Nurjazuli N (2021) Faktor risiko yang mempengaruhi kejadian malaria di Indonesia: Review literatur 2016–2020. Jurnal Kesehatan Lingkungan 11(1): 16–28. https://doi.org/10.47718/jkl.v11i1.1339
  • Lumenta APA, Sorisi AMH, Pijoh VD (2021) Pengetahuan dan sikap masyarakat terhadap penyakit malaria di desa Kolongan Kecamatan Talawaan Kabupaten Minahasa Utara. Jurnal Biomedik 13(1): e85. https://doi.org/10.35790/jbm.13.1.2021.31751
  • Maharaj R, Moonasar D, Baltazar C, Kunene S, Morris N (2016) Sustaining control: Lessons from the Lubombo spatial development initiative in southern Africa. Malaria Journal 15: e409. https://doi.org/10.1186/s12936-016-1453-9
  • Moonen B, Cohen JM, Tatem AJ, Cohen J, Hay SI, Sabot O, Smith DL (2010) A framework for assessing the feasibility of malaria elimination. Malaria Journal 9: e322. https://doi.org/10.1186/1475-2875-9-322
  • Mutabingwa TK (2005) Artemisinin-based combination therapies (ACTs): Best hope for malaria treatment but inaccessible to the needy. Acta Tropica 95(3): 305–315. https://doi.org/10.1016/j.actatropica.2005.06.009
  • Njau J, Silal SP, Kollipara A, Fox K, Balawanth R, Yuen A, White LJ, Moya M, Pillay Y, Moonasar D (2021) Investment case for malaria elimination in South Africa: A financing model for resource mobilization to accelerate regional malaria elimination. Malaria Journal 20: e344. https://doi.org/10.1186/s12936-021-03875-z
  • Poore P, Nantulya V, Møgedal S, Okuonzi S (2004) The Global Fund to fight AIDS, tuberculosis and malaria (GFATM). Health Policy and Planning 19(1): 52–53. https://doi.org/10.1093/heapol/czh007
  • Prugnolle F, Durand P, Ollomo B, Duval L, Ariey F, Arnathau C, Gonzalez J-P, Leroy E, Renaud F (2011) A fresh look at the origin of Plasmodium falciparum, the most malignant malaria agent. PLOS Pathogens 7(2): e1001283. https://doi.org/10.1371/journal.ppat.1001283
  • Putra TRI (2011) Malaria dan Permasalahannya. Jurnal Kedokteran Syiah Kuala 11(2): e105.
  • Rahmalia A, Poespoprodjo JR, Landuwulang CUR, Ronse M, Kenangalem E, Burdam FH, Thriemer K, Devine A, Price RN, Peeters Grietens K, Ley B, Gryseels C (2023) Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: A mixed-methods study. Malaria Journal 22(1): 1–16. https://doi.org/10.1186/s12936-022-04190-3
  • Raman J, Fakudze P, Sikaala CH, Chimumbwa J, Moonasar D (2021) Eliminating malaria from the margins of transmission in Southern Africa through the Elimination 8 Initiative. Transactions of the Royal Society of South Africa 76: 137–145. https://doi.org/10.1080/0035919X.2021.1915410
  • Shah NK, Valecha N (2016) Antimalarial Drug Resistance. In: Gaur D, Chitnis CE, Chauhan VS (Eds) Advances in Malaria Research, 383–407. https://doi.org/10.1002/9781118493816.ch14
  • Shahandeh K, Basseri HR (2019) Challenges and the path forward on malaria elimination intervention: A systematic review. Iranian Journal of Public Health 48(6): e1010. https://doi.org/10.18502/ijph.v48i6.2897
  • Sharp BL, Kleinschmidt I, Streat E, Maharaj R, Barnes KI, Durrheim DN, Ridl FC, Morris N, Seocharan I, Kunene S, La Grange JJP, Mthembu JD, Maartens F, Martin CL, Barreto A (2007) Seven years of regional malaria control collaboration—Mozambique, South Africa, and Swaziland. The American Journal of Tropical Medicine and Hygiene 76: 42–47. https://doi.org/10.4269/ajtmh.2007.76.42
  • Van de Walle T, Boone M, Van Puyvelde J, Combrinck J, Smith PJ, Chibale K, Mangelinckx S, D'hooghe M (2020) Synthesis and biological evaluation of novel quinoline-piperidine scaffolds as antiplasmodium agents. European Journal of Medicinal Chemistry 198: E112330. https://doi.org/10.1016/j.ejmech.2020.112330
  • Wahyuni S (2018) Polimorfisme gen pada penyakit malaria. Jurnal Kedokteran dan Kesehatan Malikussaleh 37: 40–41. https://doi.org/10.29103/averrous.v2i1.411
  • White NJ (2022) Severe malaria. Malaria Journal 248(1): 1–4. https://doi.org/10.1186/s12936-022-04199-8
  • Wirth DF, Casamitjana N, Tanner M, Reich MR (2018) Global action for training in malaria elimination. Malaria Journal 17(51): 1–3. https://doi.org/10.1186/s12936-018-2199-3
  • World Health Organization (2015) Global technical strategy for malaria 2016–2030. World Health Organization, Geneva.
  • World Health Organization (2020) World malaria report 2020: 20 years of global progress and challenges. World Health Organization, Geneva.
  • World Health Organization (2021) World malaria report 2021. World Health Organization, Geneva.